Bacterial Burden Measurement
Bacterial Burden Measurement - Related Videos
02:03
Assessing Bacterial Burden in the Mouse Spleen for Infection Studies
0 Views •
2026
Source: Madenspacher, J. H. and Fessler, M. B. A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice. J. Vis. Exp. (2016)This video demonstrates the process of quantifying bacterial load in the spleen of an infected mouse to assess the severity of infection. The homogenized spleen is serially diluted and plated to determine total bacterial burden. The resulting data provide insights into host-pathogen interactions within...
04:29
Monitoring Neutrophil Recruitment Dynamics and Bacterial Burden at the Infection Site in a Murine Model
0 Views •
2025
This video demonstrates in vivo imaging to study the neutrophil recruitment dynamics at an infection site in an immunocompromised, transgenic mouse with GFP-expressing neutrophils. It involves injecting luminescent bacteria to cause an infection. This leads to neutrophil recruitment to the infection site, whose tracking is done by imaging.
03:23
Measurement of the In Vivo Burden of Bacteria Expressing Luciferase in an Insect Larva
0 Views •
2025
This video showcases the in vivo bacterial burden measurement using Bacillus Calmette-Guérin, BCG, lux-infected insect larvae. The process involves larval homogenization, treatment with a luciferase substrate, and bioluminescence measurement to determine relative light units that correlate with bacterial burden.
06:46
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
0 Views •
Cited by 23 •
2013
Infection of the prostate may be a contributing factor in mediating pelvic pain in chronic prostatitis. We describe the procedure for preparation of standardized bacterial inoculum, instillation of bacteria into the urethra of male mice and methodology for measuring tactile allodynia in mice over time.
03:46
Malassezia-Induced Skin Inflammation and Fungal Burden Analysis in a Murine Model
0 Views •
2025
This video demonstrates Malassezia-induced skin infection in mice. Malassezia oil suspension is applied over the wounded ear, triggering inflammation and swelling of the ear tissue. Later, the ears are dissected, homogenized, and spread on an agar plate for growth. The number of colonies indicates the fungal burden resulting from skin inflammation.
FAQs
CFU results reflect the number of colony-forming units that develop from a processed specimen on growth medium after incubation. This makes them useful for culture-based comparisons of bacterial levels, but the result is specifically tied to colony formation. For broader interpretation, researchers may compare CFU data with quantitative PCR estimates of bacterial DNA.
Quantitative PCR estimates bacterial DNA, whereas plating and incubation produce a count of colony-forming units. These approaches therefore provide different quantitative readouts of a specimen. Using one or both allows researchers to examine bacterial burden through a culture-based measurement, a molecular measurement, or a comparison between the two.
Time, tissue, treatment, and host genotype are not interchangeable comparison variables. Measuring across them allows investigators to determine whether bacterial growth changes during infection, differs between tissues, responds to an intervention, or varies with host genetics. These comparisons help frame bacterial burden as an indicator of pathogen growth and immune control.
In immunology and infection studies, burden measurements provide a quantitative endpoint for examining host defense. If bacterial levels differ between host genotypes or experimental conditions, those differences can be evaluated in relation to immune control. This makes the measurement useful for relating microbial load to how effectively a host limits infection.
Researchers can compare bacterial burden between treated and relevant comparison samples, using measurements collected across the study design. A lower or higher measured burden provides a quantitative basis for assessing how the treatment is associated with bacterial growth. The same framework can be applied across different time points or tissues to examine treatment-related patterns.
Linking bacterial burden with inflammation or disease outcomes extends the measurement beyond a microbial count. Researchers can examine whether differences in microbial load accompany differences in inflammatory or disease-related outcomes. In infection models, this pairing helps connect pathogen growth with the host response and with the severity-related features being studied.
Sampling multiple tissues allows bacterial levels to be compared by location rather than treating the host as a single measurement. That comparison can show whether burden differs among tissues and can be integrated with time, treatment, or host-genotype comparisons. Such designs support more precise analysis of infection patterns and immune control.